NYLI WMC Value Fund A (MAPAX)
31.32
-0.05
(-0.16%)
USD |
Dec 30 2025
Returns Chart
Key Stats
| Net Expense Ratio | Total Assets Under Management | Weighted Average Dividend Yield | Turnover Ratio (Generic) |
|---|---|---|---|
| 1.02% | 945.89M | 2.19% | 36.00% |
| 1 Year Fund Level Flows | 1 Year Total Returns (Daily) | Annualized Total Returns Since Inception (Daily) | Max Drawdown (Since Inception) |
| -155.39M | 15.46% | Upgrade | Upgrade |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term appreciation of capital. The Fund also seeks to earn income as a secondary objective. The Fund normally invests at least 65% of its total assets in equity-type securities. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Multi Cap Value |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US |
| Peer Group | Multi-Cap Value Funds |
| Global Macro | Equity North America |
| US Macro | Multi-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Growth & Income Funds |
| Fund Owner Firm Name | New York Life Investments |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Net Fund Flows Versus Peer Group
1 Month
% Rank:
79
-1.391B
Peer Group Low
2.015B
Peer Group High
1 Year
% Rank:
73
-155.39M
-7.919B
Peer Group Low
8.601B
Peer Group High
3 Months
% Rank:
76
-2.483B
Peer Group Low
4.261B
Peer Group High
3 Years
% Rank:
70
-11.51B
Peer Group Low
11.79B
Peer Group High
6 Months
% Rank:
76
-5.060B
Peer Group Low
4.371B
Peer Group High
5 Years
% Rank:
5
-14.06B
Peer Group Low
40.52B
Peer Group High
YTD
% Rank:
73
-7.806B
Peer Group Low
6.989B
Peer Group High
10 Years
% Rank:
15
-28.09B
Peer Group Low
72.32B
Peer Group High
Date Unavailable
Risk
Performance Versus Peer Group
Annual Total Returns Versus Peers
As of December 31, 2025.
*Indicates data for the year is incomplete.
Asset Allocation
As of October 31, 2025.
| Type | % Net |
|---|---|
| Cash | -0.03% |
| Stock | 98.74% |
| Bond | 0.00% |
| Convertible | 0.00% |
| Preferred | 0.00% |
| Other | 1.29% |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| Alphabet, Inc. | 4.81% | 313.81 | -0.24% |
| JPMorgan Chase & Co. | 4.11% | 322.30 | -0.35% |
| Johnson & Johnson | 2.92% | 207.03 | 0.06% |
| Merck & Co., Inc. | 2.40% | 105.28 | -0.74% |
| UnitedHealth Group, Inc. | 2.38% | 330.24 | -0.58% |
| Cisco Systems, Inc. | 2.25% | 77.05 | -0.47% |
| Sempra | 1.88% | 88.28 | -0.91% |
| Pfizer Inc. | 1.82% | 24.90 | -0.34% |
| American International Group, Inc. | 1.81% | 85.58 | -0.64% |
| Archer-Daniels-Midland Co. | 1.76% | 57.50 | -1.14% |
Fees & Availability
| Fees | |
| Actual 12B-1 Fee | 0.25% |
| Actual Management Fee | 0.66% |
| Administration Fee | -- |
| Maximum Front Load | 5.50% |
| Maximum Deferred Load | -- |
| Maximum Redemption Fee | -- |
| General Availability | |
| Available for Insurance Product | No |
| Available for RRSP | No |
| Purchase Details | |
| Open to New Investors |
|
| Minimum Initial Investment | 15000.00 None |
| Minimum Subsequent Investment | 0.00 None |
Basic Info
| Investment Strategy | |
| The Fund seeks long-term appreciation of capital. The Fund also seeks to earn income as a secondary objective. The Fund normally invests at least 65% of its total assets in equity-type securities. |
| General | |
| Security Type | Mutual Fund |
| Equity Style | Multi Cap Value |
| Broad Asset Class | US Equity |
| Broad Category | Equity |
| Global Peer Group | Equity US |
| Peer Group | Multi-Cap Value Funds |
| Global Macro | Equity North America |
| US Macro | Multi-Cap Funds |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Prospectus Objective | Growth & Income Funds |
| Fund Owner Firm Name | New York Life Investments |
| Broad Asset Class Benchmark Index | |
| ^SPXTR | 100.0% |
Fundamentals
| General | |
| Distribution Yield | -- |
| Dividend Yield TTM (12-29-25) | 1.43% |
| 30-Day SEC Yield (6-30-21) | 0.78% |
| 7-Day SEC Yield | -- |
| Number of Holdings | 67 |
| Stock | |
| Weighted Average PE Ratio | 22.94 |
| Weighted Average Price to Sales Ratio | 3.884 |
| Weighted Average Price to Book Ratio | 5.190 |
| Weighted Median ROE | 27.39% |
| Weighted Median ROA | 7.17% |
| ROI (TTM) | 12.87% |
| Return on Investment (TTM) | 12.87% |
| Earning Yield | 0.0530 |
| LT Debt / Shareholders Equity | 1.018 |
| Number of Equity Holdings | 63 |
As of October 31, 2025
Growth Metrics
| EPS Growth (1Y) | 9.71% |
| EPS Growth (3Y) | 5.37% |
| EPS Growth (5Y) | 10.09% |
| Sales Growth (1Y) | 5.68% |
| Sales Growth (3Y) | 5.86% |
| Sales Growth (5Y) | 7.81% |
| Sales per Share Growth (1Y) | 7.13% |
| Sales per Share Growth (3Y) | 7.47% |
| Operating Cash Flow - Growth Rate (3Y) | 0.24% |
As of October 31, 2025
Fund Details
Top Portfolio Holders
| Name | % Weight |
|---|---|
| Portfolio A | 5.00% |
| Portfolio B | 3.50% |
| Portfolio C | 2.25% |
Excel Add-In Codes
| Name: =YCI("M:MAPAX", "name") |
| Broad Asset Class: =YCI("M:MAPAX", "broad_asset_class") |
| Broad Category: =YCI("M:MAPAX", "broad_category_group") |
| Prospectus Objective: =YCI("M:MAPAX", "prospectus_objective") |
| To find the codes for any of our securities and financial metrics, see our Complete Excel Reference. |